Inrus Pharma Private Limited
About Inrus Pharma Private Limited
Data last updated:
Inrus Pharma Private Limited is a private limited company based in Margao, Goa, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 28 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U74999GA2018PTC013624. Its GSTIN is 30AAECI9211L1ZP (Goa).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Ujjal Saha and Tanushree Paul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. A – 7 2nd Floor Rohoni Appts Behind Holy Spirit Church Old Market, Margao, Goa, India – 403601.
As per the financials filed for FY 2025, the company reported a revenue of ₹85.56 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹3.19 Lakh (net margin 3.7%) and EBITDA of ₹4.79 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 62% over five years.
As per MCA filings, the company has open charges of ₹8.97 Lakh on record.
Company details
Contact details
Inrus Pharma Private Limited's registered office is in Margao, Goa. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. A – 7 2nd Floor Rohoni Appts Behind Holy Spirit Church Old Market, Margao, Goa, India – 403601
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Inrus Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inrus Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inrus Pharma Private Limited, buy the company report.
Financials of Inrus Pharma Private Limited
FY 2025 filings availableInrus Pharma Private Limited reported revenue of ₹85.56 Lakh (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 62% over five years, including 32% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inrus Pharma Private Limited, buy the company report.
Board of directors of Inrus Pharma Private Limited
Inrus Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ujjal Saha | Director | 28 Jun 2018 | 8 Years 3 Months | Current |
| Tanushree Paul | Director | 02 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Inrus Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bay Leaf Wellness Private Limited | ₹85.6 Lakh (FY 2021) | -22.0% | New Delhi, Delhi, India | |||
| Maleka Polycot Pvt Ltd | ₹85.58 Lakh (FY 2025) | -45.0% | Ahmedabad, Gujarat, India | |||
| Ramdeo Marble & Granites Pvt Ltd | ₹85.58 Lakh (FY 2025) | -76.0% | Kolkata, West Bengal, India | |||
| United Energy Concepts Private Limited | ₹85.57 Lakh (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Zukasa Exports Private Limited | ₹85.56 Lakh (FY 2022) | 405.0% | Kolkata, West Bengal, India | |||
| Inrus Pharma Private Limitedthis company | ₹85.56 Lakh (FY 2025) | ₹3.19 Lakh | 3.7% | 32.0% | Margao, Goa, India | |
| Ideacraft Advisors Private Limited | ₹85.55 Lakh (FY 2024) | 282.0% | Nagaon, Maharashtra, India | |||
| Sutirth Ayu Pharma Private Limited | ₹85.54 Lakh (FY 2025) | -31.0% | Ahmedabad, Gujarat, India | |||
| Ailron Pharma Private Limited | ₹85.54 Lakh (FY 2024) | -9.0% | Dist-Cuttack, Odisha, India | |||
| Vindrasree Private Limited | ₹85.53 Lakh (FY 2025) | Chennai, Tamil Nadu, India | ||||
| Lenka Printers Limited | ₹85.52 Lakh (FY 2019) | 11.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Inrus Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Dec 2024 | 101038014 | Hdfc Bank Limited | ₹8.97 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Inrus Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inrus Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inrus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AAECI9211L1ZP | Goa | Active | 07 Mar 2019 |
To see the full GST registrations and return filing status of Inrus Pharma Private Limited, buy the company report.
Recent activity
Inrus Pharma Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Tanushree Paul was appointed as Director on 02 Sep 2024.
Frequently asked questions
Inrus Pharma is an active private limited company based in Margao, Goa, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 28 June 2018 (8+ years old) and is registered under CIN U74999GA2018PTC013624.
Inrus Pharma has 2 current directors:
- Ujjal Saha - Director
- Tanushree Paul - Director
The latest financial statements of Inrus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Inrus Pharma is 30AAECI9211L1ZP, registered in Goa.
The CIN (Corporate Identification Number) of Inrus Pharma is U74999GA2018PTC013624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inrus Pharma was incorporated on 28 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Inrus Pharma by revenue are Bay Leaf Wellness Private Limited, Maleka Polycot Pvt Ltd, Ramdeo Marble & Granites Pvt Ltd, United Energy Concepts Private Limited, Zukasa Exports Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Tanushree Paul was appointed as Director on 02 Sep 2024. Tanushree Paul ceased to be Additional Director on 30 Dec 2020. Sanket Narcinva Verenkar Shet ceased to be Director on 02 Sep 2020. Inrus Pharma has 4 board changes on record in total.
The registered office of Inrus Pharma is at Flat No. A – 7 2nd Floor Rohoni Appts Behind Holy Spirit Church Old Market, Margao, Goa, India – 403601.
Inrus Pharma operates in the business services industry, in the miscellaneous business activities segment.
Inrus Pharma has open charges of ₹8.97 Lakh and no satisfied charges on record as per latest MCA filings.